These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 681806

  • 1. Chronic iron overload: new chelators and new strategies.
    Fairbanks VF.
    J Lab Clin Med; 1978 Aug; 92(2):141-3. PubMed ID: 681806
    [No Abstract] [Full Text] [Related]

  • 2. Iron metabolism and chelation therapy in hemosiderosis.
    Graziano JH.
    Curr Top Hematol; 1978 Aug; 1():127-50. PubMed ID: 400529
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of continuous desferrioxamine administration in adults with transfusional hemosiderosis.
    Cooper B, Bunn HF, Propper RD, Nathan DG, Rosenthal DS, Moloney WC.
    Trans Assoc Am Physicians; 1977 Aug; 90():335-41. PubMed ID: 611665
    [No Abstract] [Full Text] [Related]

  • 4. Iron metabolism and iron chelation in the thalassaemia disorders.
    Pippard MJ.
    Haematologica; 1990 Aug; 75 Suppl 5():66-71. PubMed ID: 2086383
    [No Abstract] [Full Text] [Related]

  • 5. [Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease].
    Cartei G, Cazzavillan M, Chisesi T, Battista R, Barbui T, Dini E.
    Minerva Med; 1978 Mar 17; 69(13):811-21. PubMed ID: 643223
    [No Abstract] [Full Text] [Related]

  • 6. Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias.
    Pippard MJ, Weatherall DJ.
    Haematologia (Budap); 1984 Mar 17; 17(1):17-24. PubMed ID: 6724353
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of desferrioxamine and ascorbic acid for the treatment of chronic iron overload.
    Nienhuis AW, Delea C, Aamodt R, Bartter F, Anderson WF.
    Birth Defects Orig Artic Ser; 1976 Mar 17; 12(8):177-85. PubMed ID: 795481
    [No Abstract] [Full Text] [Related]

  • 8. [Comparative evaluation of two models of hemosiderosis for analysis of iron chelators].
    Minina LT, Prostakova TM, Meshchano AIu, Kol'tsova GN, Bovenko VN.
    Biull Eksp Biol Med; 1996 Sep 17; 122(9):359-60. PubMed ID: 8974501
    [No Abstract] [Full Text] [Related]

  • 9. The selection and evaluation of new chelating agents for the treatment of iron overload.
    Pitt CG, Gupta G, Estes WE, Rosenkrantz H, Metterville JJ, Crumbliss AL, Palmer RA, Nordquest KW, Hardy KA, Whitcomb DR, Byers BR, Arceneaux JE, Gaines CG, Sciortino CV.
    J Pharmacol Exp Ther; 1979 Jan 17; 208(1):12-8. PubMed ID: 759605
    [Abstract] [Full Text] [Related]

  • 10. Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.
    Giardina PJ, Grady RW.
    Semin Hematol; 1995 Oct 17; 32(4):304-12. PubMed ID: 8560288
    [Abstract] [Full Text] [Related]

  • 11. [Use of desferal in treatment of sideroses of different origin. (Literature review)].
    Turbina NS.
    Probl Gematol Pereliv Krovi; 1968 Jul 17; 13(7):47-52. PubMed ID: 4898933
    [No Abstract] [Full Text] [Related]

  • 12. [Iron chelate treatment of hereditary sideroblastic anemia complicated by hemochromatosis].
    Kremp L, Girot R, Alliot S, Najean Y, Douchain F, Hongre JF.
    Arch Fr Pediatr; 1983 Jul 17; 40(6):475-7. PubMed ID: 6625846
    [Abstract] [Full Text] [Related]

  • 13. [Guidelines for diagnosis and treatment of secondary iron overload in patients with congenital anemia].
    Cario H, Grosse R, Janssen G, Jarisch A, Meerpohl J, Strauss G, German hematology societies (GPOH and DGHO).
    Klin Padiatr; 2010 Nov 17; 222(6):399-406. PubMed ID: 20862634
    [Abstract] [Full Text] [Related]

  • 14. Iron chelating therapy in thalassemia: current problems.
    Russo G.
    Haematologica; 1990 Nov 17; 75 Suppl 5():84-8. PubMed ID: 2086385
    [No Abstract] [Full Text] [Related]

  • 15. Long-term efficacy of deferoxamine iron chelation therapy in adults with acquired transfusional iron overload.
    Schafer AI, Rabinowe S, Le Boff MS, Bridges K, Cheron RG, Dluhy R.
    Arch Intern Med; 1985 Jul 17; 145(7):1217-21. PubMed ID: 3925909
    [Abstract] [Full Text] [Related]

  • 16. Chelation therapy for iron overload.
    Nutr Rev; 1980 May 17; 38(5):185-7. PubMed ID: 7207885
    [No Abstract] [Full Text] [Related]

  • 17. Management of iron overload in the pediatric patient.
    Cohen A.
    Hematol Oncol Clin North Am; 1987 Sep 17; 1(3):521-44. PubMed ID: 3329185
    [Abstract] [Full Text] [Related]

  • 18. [Differential diagnosis of anemias associated with iron metabolism disorders].
    Apollonova LA.
    Ter Arkh; 1970 Jul 17; 42(7):75-9. PubMed ID: 5477572
    [No Abstract] [Full Text] [Related]

  • 19. Ferrioxamine excretion in iron-loaded man.
    Pippard MJ, Callender ST, Finch CA.
    Blood; 1982 Aug 17; 60(2):288-94. PubMed ID: 7093519
    [No Abstract] [Full Text] [Related]

  • 20. Vitamin C and iron.
    Nienhuis AW.
    N Engl J Med; 1981 Jan 15; 304(3):170-1. PubMed ID: 7442737
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.